Combination of sorafenib and TACE inhibits portal vein invasion for intermediate stage HCC: a single center retrospective controlled study.
about
Combination of sorafenib and TACE inhibits portal vein invasion for intermediate stage HCC: a single center retrospective controlled study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Combination of sorafenib and T ...... etrospective controlled study.
@en
Combination of sorafenib and T ...... etrospective controlled study.
@nl
type
label
Combination of sorafenib and T ...... etrospective controlled study.
@en
Combination of sorafenib and T ...... etrospective controlled study.
@nl
prefLabel
Combination of sorafenib and T ...... etrospective controlled study.
@en
Combination of sorafenib and T ...... etrospective controlled study.
@nl
P2093
P2860
P356
P1433
P1476
Combination of sorafenib and T ...... etrospective controlled study.
@en
P2093
Chuansheng Zheng
Hongsen Zhang
P2860
P304
79012-79022
P356
10.18632/ONCOTARGET.20745
P407
P577
2017-09-08T00:00:00Z